Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.
about
Interactions between pharmaceutical representatives and doctors in training. A thematic reviewTeaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudesJudging whether a patient is actually improving: more pitfalls from the science of human perceptionCharacteristics and impact of drug detailing for gabapentinJapanese practicing physicians' relationships with pharmaceutical representatives: a national surveyInformation from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic reviewContact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habitsPrescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug AdministrationTurkish Final Year Medical Students' Exposure to and Attitudes Concerning Drug Company Interactions: A Perspective from a Minimally Regulated Environment for Medical StudentsViolations of exhibiting and FDA rules at an American Psychiatric Association annual meeting.Soft targets: nurses and the pharmaceutical industry.Exposure to the drug company marketing in Greece: Interactions and attitudes in a non-regulated environment for medical students.Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.Physician attitudes toward industry: a view across the specialtiesThe spectre of race in American medicine.Establishing the need and identifying goals for a curriculum in medical business ethics: a survey of students and residents at two medical centers in Missouri.Revisiting financial conflicts of interest in FDA advisory committeesAppropriateness of collaborations between industry and the medical profession: physicians' perceptions.Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures.What nurse practitioners should know about direct-to-consumer advertising of prescription medications.Of money and trust in biomedical care.Student feedback about The Skeptic Doctor, a module on pharmaceutical promotionPhysicians and drug representatives: exploring the dynamics of the relationshipPerceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional ActivitiesValidity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic reviewTeaching trainees to negotiate research collaborations with industry: a mentorship model.Of money and trust in medical care redux.Pharmaceutical promotions and conflict of interest in nurse practitioner's decision making: the undiscovered country.Pharmacists' Perceptions of the Influence of Interactions with the Pharmaceutical Industry on Clinical Decision-Making.Medical Schools' Industry Interaction Policies Not Associated With Trainees' Self-Reported Behavior as Residents: Results of a National Survey.A question of method. The ethics of managing conflicts of interest.Addressing Antibiotic Abuse in China: An Experimental Audit Study.Using Logic Analysis to Evaluate Knowledge Transfer Initiatives: The Case of the Research Collective on the Organization of Primary Care ServicesWhat do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?Physicians' intent to comply with the American Medical Association's guidelines on gifts from the pharmaceutical industry.Evaluating interventions aimed at promoting information utilization in organizations and systemsHow to manage conflicts of interest with industry?Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.Medical students' attitudes to and contact with the pharmaceutical industry: a survey at eight German university hospitals
P2860
Q24549713-340BC82A-82E2-4723-A209-579DC59405E4Q24806614-D5F14DF2-EE87-45ED-9EB9-708EFCDE495BQ27694551-23C096E7-B1A7-4AF6-8A60-D066538B6B5EQ28469192-7139D4FB-E90A-4AF9-9710-38AF49C4523AQ28475099-54CDB95C-115D-474F-9EA6-702C474513D3Q28475841-E475CE50-CC36-4228-94A2-E8A48BE877A8Q28543878-DD73C7AA-8666-46D8-8D51-5839522D7301Q28551840-2B3B91F9-CFAB-430E-84A7-39BC7FEAA68CQ28555046-9DF92FF2-A174-430B-B32C-4AB64957C027Q30352401-BDE3D52F-67C2-4003-A9BF-3F6061FB59AAQ33318540-6DDE5D4A-D80E-4A64-B1EC-7CBA67E97614Q33753326-EAC312E7-7EEE-44DF-9F46-AF86AE3CBE21Q33815142-04C63177-C8E0-4D08-8589-C8F5B64BE86DQ33931436-5C577CB8-D26A-48AD-8C36-636E1DFA95A7Q33938603-75EE97BA-C601-486A-897A-99AF55C6F3B7Q34039428-43A5F5A4-6444-4F4B-B325-6F6CD2BC85C2Q34362925-64245C3D-210D-47C1-BBA6-F9DE06DA6DBDQ34460311-EEFF5800-832F-46C7-BDFA-A0CAD745E186Q34490193-67BF7CDE-A373-4F37-906E-980DCAA126D6Q34740740-0A061044-C74E-415F-8490-28F5BDBFE6FCQ35203398-C73226AB-576A-4F96-B47F-2F733512E545Q35334235-B92E1385-6810-49B0-8104-A0E2EF3E3546Q35649211-284A46E2-977B-415B-9829-056F47865F4AQ35683129-EA558D13-D9BE-48E6-8E08-3FB48C3B744EQ35810078-57AD1C0E-64F6-40B4-8040-BE9992856904Q35852800-B47A537A-538F-42D7-AB76-19B34442F7AEQ35920534-1798B9DD-35D1-4A3F-A0F4-B0123773DB52Q35964324-E0BCAA67-659A-497D-AB00-BBBBE90C10EBQ36144205-CAB51B8C-C1C7-49B0-A214-12BBDC424D12Q36161200-634402F8-F80C-4974-AF14-B0BA1AFDA3E6Q36362502-05F4764C-2030-4D9A-9E2D-9A27009F9A35Q36465802-E48402A3-A069-44F1-BD0D-6A0F5AC97DBDQ36645966-51ED3AB1-EDDF-400B-9A51-8A6B13B854B1Q36723985-DBB6A0DB-81BC-448C-A027-5CFCD5A586C9Q36895261-F19F4058-8BB2-4832-942E-9B3C3B388259Q37005252-9E7AB447-1009-4866-8A44-B68710AF15F6Q37103416-27914BC8-1C81-4CB8-B667-7039BDABBBA6Q37127425-9158D38F-4E31-41C1-BDA2-9D699016EE77Q37185115-97E1E93F-DAC7-47BE-8CE6-2E28ADB5C251Q37202047-E4731409-E605-45FC-AAD4-0DCFCA87A3BC
P2860
Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Of principles and pens: attitu ...... aceutical industry promotions.
@en
Of principles and pens: attitu ...... aceutical industry promotions.
@nl
type
label
Of principles and pens: attitu ...... aceutical industry promotions.
@en
Of principles and pens: attitu ...... aceutical industry promotions.
@nl
prefLabel
Of principles and pens: attitu ...... aceutical industry promotions.
@en
Of principles and pens: attitu ...... aceutical industry promotions.
@nl
P2093
P1476
Of principles and pens: attitu ...... aceutical industry promotions.
@en
P2093
Shlipak MG
Steinman MA
P304
P356
10.1016/S0002-9343(01)00660-X
P407
P577
2001-05-01T00:00:00Z